Ellen de Brabander - 01 Nov 2023 Form 4 Insider Report for Elanco Animal Health Inc (ELAN)

Reporting relationship: Executive Vice President of Innovation and Regulatory Affairs
Issuer ticker: ELAN
Reported as of: 01 Nov 2023
Net transaction value: -$97,476
SEC form: 4
Accepted by SEC: 03 Nov 2023, 16:51:55 UTC
Prior SEC filing: 03 Oct 2023
Next SEC filing: 07 Dec 2023
Source filing: View source filing
Reporting owner signature: /s/ Catherine S. Powell, as Attorney-in-Fact for Ellen de Brabander

Key filing fact

Ellen de Brabander filed Form 4 for Elanco Animal Health Inc (ELAN) on 03 Nov 2023.

Key facts

This page summarizes Ellen de Brabander's Form 4 filing for Elanco Animal Health Inc (ELAN).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 03 Nov 2023, 16:51.

Change

Previous filing in this sequence was filed on 03 Oct 2023.
Current net transaction value: -$97,476.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ELAN transaction

Common Stock

Tax liability

Transaction value: $97,476
Shares: -11,295
Change %: -12%
Price: $8.63
Shares after: 80,511
Date: 01 Nov 2023
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents shares tendered to the Company to cover the Reporting Person's tax liability upon vesting of restricted stock units previously awarded under the Amended and Restated 2018 Elanco Stock Plan.

SEC remarks

Executive Vice President of Innovation and Regulatory Affairs